A study on reversing HCC drug resistance showed that APC/C-CDC20 complex-mediated degradation of p21 ubiquitination was prevented by CMTM6, affecting HCC response to TACE treatment [34]. Here, CDC20 is linked to hepatocellular carcinoma.